Logo image of CTEV

CLARITEV CORP (CTEV) Stock Fundamental Analysis

USA - NYSE:CTEV - US62548M2098 - Common Stock

70.385 USD
+0.7 (+1%)
Last: 10/27/2025, 9:36:25 AM
Fundamental Rating

2

Taking everything into account, CTEV scores 2 out of 10 in our fundamental rating. CTEV was compared to 35 industry peers in the Health Care Technology industry. CTEV has a bad profitability rating. Also its financial health evaluation is rather negative. CTEV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CTEV had negative earnings in the past year.
CTEV had a positive operating cash flow in the past year.
In the past 5 years CTEV reported 4 times negative net income.
Each year in the past 5 years CTEV had a positive operating cash flow.
CTEV Yearly Net Income VS EBIT VS OCF VS FCFCTEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

With a Return On Assets value of -13.08%, CTEV perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
CTEV has a Return On Invested Capital of 1.03%. This is in the better half of the industry: CTEV outperforms 68.57% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CTEV is below the industry average of 6.80%.
Industry RankSector Rank
ROA -13.08%
ROE N/A
ROIC 1.03%
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
CTEV Yearly ROA, ROE, ROICCTEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

Looking at the Operating Margin, with a value of 6.72%, CTEV is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CTEV has declined.
CTEV's Gross Margin of 74.43% is fine compared to the rest of the industry. CTEV outperforms 77.14% of its industry peers.
In the last couple of years the Gross Margin of CTEV has declined.
Industry RankSector Rank
OM 6.72%
PM (TTM) N/A
GM 74.43%
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
CTEV Yearly Profit, Operating, Gross MarginsCTEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

CTEV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CTEV has about the same amount of shares outstanding.
Compared to 5 years ago, CTEV has less shares outstanding
Compared to 1 year ago, CTEV has a worse debt to assets ratio.
CTEV Yearly Shares OutstandingCTEV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
CTEV Yearly Total Debt VS Total AssetsCTEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of -0.27, we must say that CTEV is in the distress zone and has some risk of bankruptcy.
CTEV has a Altman-Z score of -0.27. This is comparable to the rest of the industry: CTEV outperforms 48.57% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.27
ROIC/WACC0.14
WACC7.54%
CTEV Yearly LT Debt VS Equity VS FCFCTEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 0.98 indicates that CTEV may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.98, CTEV is doing worse than 77.14% of the companies in the same industry.
CTEV has a Quick Ratio of 0.98. This is a bad value and indicates that CTEV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.98, CTEV is not doing good in the industry: 77.14% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.98
CTEV Yearly Current Assets VS Current LiabilitesCTEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

3

3. Growth

3.1 Past

CTEV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.25%.
The Revenue has decreased by -2.03% in the past year.
The Revenue has been decreasing by -1.09% on average over the past years.
EPS 1Y (TTM)-0.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.3%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%3.47%

3.2 Future

The Earnings Per Share is expected to grow by 25.00% on average over the next years. This is a very strong growth
CTEV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.88% yearly.
EPS Next Y76.94%
EPS Next 2Y35.5%
EPS Next 3Y25%
EPS Next 5YN/A
Revenue Next Year1.46%
Revenue Next 2Y2.57%
Revenue Next 3Y2.88%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CTEV Yearly Revenue VS EstimatesCTEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CTEV Yearly EPS VS EstimatesCTEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 -20 -40 -60 -80

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CTEV. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTEV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTEV Price Earnings VS Forward Price EarningsCTEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

CTEV's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTEV is cheaper than 82.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.39
CTEV Per share dataCTEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200

4.3 Compensation for Growth

A more expensive valuation may be justified as CTEV's earnings are expected to grow with 25.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.5%
EPS Next 3Y25%

0

5. Dividend

5.1 Amount

CTEV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLARITEV CORP

NYSE:CTEV (10/27/2025, 9:36:25 AM)

70.385

+0.7 (+1%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-07 2025-11-07
Inst Owners40.19%
Inst Owner ChangeN/A
Ins Owners6.91%
Ins Owner Change5.23%
Market Cap1.16B
Revenue(TTM)935.54M
Net Income(TTM)-663374000
Analysts80
Price Target71.74 (1.93%)
Short Float %8.04%
Short Ratio5.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-10.5%
Min EPS beat(2)-23.58%
Max EPS beat(2)2.57%
EPS beat(4)2
Avg EPS beat(4)-19.98%
Min EPS beat(4)-73.58%
Max EPS beat(4)14.65%
EPS beat(8)5
Avg EPS beat(8)-182.55%
EPS beat(12)6
Avg EPS beat(12)-287.29%
EPS beat(16)8
Avg EPS beat(16)-201.21%
Revenue beat(2)2
Avg Revenue beat(2)2.18%
Min Revenue beat(2)1.86%
Max Revenue beat(2)2.51%
Revenue beat(4)2
Avg Revenue beat(4)-0.45%
Min Revenue beat(4)-3.29%
Max Revenue beat(4)2.51%
Revenue beat(8)2
Avg Revenue beat(8)-2.36%
Revenue beat(12)4
Avg Revenue beat(12)-2.64%
Revenue beat(16)6
Avg Revenue beat(16)-2.02%
PT rev (1m)0%
PT rev (3m)124.47%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.65%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.82%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.64%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.24
P/FCF N/A
P/OCF 16.42
P/B N/A
P/tB N/A
EV/EBITDA 11.39
EPS(TTM)-40.5
EYN/A
EPS(NY)-11.42
Fwd EYN/A
FCF(TTM)-3.34
FCFYN/A
OCF(TTM)4.29
OCFY6.09%
SpS56.8
BVpS-2.42
TBVpS-273.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.08%
ROE N/A
ROCE 1.3%
ROIC 1.03%
ROICexc 1.04%
ROICexgc 16.29%
OM 6.72%
PM (TTM) N/A
GM 74.43%
FCFM N/A
ROA(3y)-13.68%
ROA(5y)-9.22%
ROE(3y)-665.39%
ROE(5y)-402.43%
ROIC(3y)2.41%
ROIC(5y)N/A
ROICexc(3y)2.48%
ROICexc(5y)N/A
ROICexgc(3y)66.67%
ROICexgc(5y)N/A
ROCE(3y)3.05%
ROCE(5y)N/A
ROICexgc growth 3Y-40.96%
ROICexgc growth 5Y-27.14%
ROICexc growth 3Y-26.84%
ROICexc growth 5Y-14.89%
OM growth 3Y-33.57%
OM growth 5Y-22.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.14%
GM growth 5Y-2.61%
F-Score4
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 9.19
Cap/Depr 28.61%
Cap/Sales 13.43%
Interest Coverage 0.23
Cash Conversion 14.07%
Profit Quality N/A
Current Ratio 0.98
Quick Ratio 0.98
Altman-Z -0.27
F-Score4
WACC7.54%
ROIC/WACC0.14
Cap/Depr(3y)25.06%
Cap/Depr(5y)22.79%
Cap/Sales(3y)10.77%
Cap/Sales(5y)9.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.3%
EPS Next Y76.94%
EPS Next 2Y35.5%
EPS Next 3Y25%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y-5.92%
Revenue growth 5Y-1.09%
Sales Q2Q%3.47%
Revenue Next Year1.46%
Revenue Next 2Y2.57%
Revenue Next 3Y2.88%
Revenue Next 5YN/A
EBIT growth 1Y-56%
EBIT growth 3Y-37.5%
EBIT growth 5Y-23.25%
EBIT Next Year145.04%
EBIT Next 3Y35.49%
EBIT Next 5YN/A
FCF growth 1Y-151.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.17%
OCF growth 3Y-35.69%
OCF growth 5Y-17.66%

CLARITEV CORP / CTEV FAQ

Can you provide the ChartMill fundamental rating for CLARITEV CORP?

ChartMill assigns a fundamental rating of 2 / 10 to CTEV.


Can you provide the valuation status for CLARITEV CORP?

ChartMill assigns a valuation rating of 1 / 10 to CLARITEV CORP (CTEV). This can be considered as Overvalued.


What is the profitability of CTEV stock?

CLARITEV CORP (CTEV) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for CTEV stock?

The Earnings per Share (EPS) of CLARITEV CORP (CTEV) is expected to grow by 76.94% in the next year.